The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Go ballistic…
DYOR
Mcap is really small compared to this update. Free float is even tiny , with volume this will be 20p
Looks like a reason to buy..
Could
This be on takeover territory now?
…
Can anyone get a quote to sell?
How is this transformative?
, with £30m debt
cash £6m
mms risen this, after few sells this goes down......
bullish rns doesn't match the debt issue
£30m debt
this will take another 5:years to clear....... look at the rns
per year they managed on £4m to clear debt
This update is transformative
Increased profit margins sounds promising, the market clearly likes the update but lacking in any financial numbers. Spread on share price recently been awful though.
It didn’t show green on IG and Main London, i want to buy .. couldn’t
Missed it, it is already above 10p
Anyway bought some
Agreed.
Fabulous to see they're finally turning the corner, despite it being early days.
I suspect they'll be on some of the bigger players shopping list down here.
Sounds like they are trading well. The statement is a bit short on facts and figures again, but compliance with covenants is also a big objective tick. If they can get through the restructuring and see material margin gains as a result, then the upside potential from this level of valuation is fantastic? ATB
Please Ignore previous post somehow managed to post on wrong Forum. What a Doughnut...
Looking to add but going to hold off until next weeks trading update, See Blackrock has added to holdings in todays RNS
I know, ridiculous news flow for a once half decent company.
Fund raising? New meaningful order wins? Takeover from somewhere? More bad news? Listed in 1998 and hit around almost 500p at one point?
Did the last results warrant a 35% decline in share price?
How much damage did Phil and Nick do to this company?
What a strange (excessive) amount of low volume sell trades today, practically all of them below 500 shares each, it's almost as if someone was deliberately trying to lower the bid price???
I certainly agree Chrisjse, but obviously Mr. Parker does not ! Sad to see him selling so soon after his purchase.
I would have thought significantly reduced borrowings was very positive!
Suprised this chat is so quiet following interim results, not much positive to take out of that except the aerospace increase, shame it's such small section of the company.
I keep looking in at this company and it's clearly struggling but surviving and limping along. Talk of hoping or suggesting financial year 2025 will bring in more blue chip customer orders when markets are expected to recover.
I think the 'market' was hoping for better and I don't know what needs to be done to turn this around to what looked like better days. Listed company since 1988?
A good achievement in a tough year:
"We made excellent progress on the key strategic goal of improving the Group's cash generation with cash generated from operations of £11.4 million (H1 2023: £0.5 million)"
Carclo’s market in medical devices is projected to grow to over £700 billion which considering they have a valuation of £8 million makes for incredible potential.
If the settlement payment has put a big dent in their debt and their margins have improved the next results updates could be the start of a major upgrade!!
Get in early before the rise.
If they can get the share price up to a £1 the directors can award themselves as many shares as they like!